Lubiprostone (amitiza) for chronic constipation.
D000527:Alprostadil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018118:Chloride Channels / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003248:Constipation / Q000188:drug therapy*; D005227:Fatty Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000068238:Lubiprostone; D011247:Pregnancy
D018118:Chloride Channels; D005227:Fatty Acids; D005765:Gastrointestinal Agents; D000068238:Lubiprostone; D000527:Alprostadil